Duck Medicine and Vaccines Market, By Type (Medicine, Vaccines), By Application (Farm, Government), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Description

Duck Medicine And Vaccines Market is estimated to be valued at USD 2,560 Mn in 2026 and is expected to reach USD 4,265 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2,560 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.60%	2033 Value Projection:	USD 4,265 Mn

Duck farming plays a vital role in the poultry industry, which is one of the fastest-growing sectors in the world. Duck diseases are a major cause of concern because they can affect finances of small and landless farmers. Ducks are important to rural livelihoods because they provide a steady supply of meat and eggs. One of the most important measures to prevent outbreaks is to maintain the health of the ducks. Viruses have been reported to have more devastating consequences for duck productivity than other diseases that affect ducks. The most prevalent disease in ducks is Escherichia coli due to poor farm hygiene. Ducks are highly vulnerable to mycotoxins, notably aflatoxin, a toxic and carcinogenic metabolite of Aspergillus flavus that primarily affects the liver. This is a persistent issue that isn't always recognized. A toxin binder, which is a substance added to poultry feed in minute quantities to neutralize or immobilize harmful chemicals, mycotoxins or endotoxins should be included in duck diets on a regular basis. Proper vaccination and treatment can help prevent diseases in ducks.

Market Dynamics

The increasing research and development activities by scientists to develop vaccines for the diseases of ducks are expected to drive the market growth during the forecast period. For instance, in September 2020, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university aiming to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks. In ducks, Riemerellosis causes 5-75 percent mortality and more than 50 percent mortality in ducklings under the age of five weeks.

Key features of the study

This report provides an in-depth analysis of the global duck medicine and vaccines market, and provides market size (USD million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global duck medicine and vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global duck medicine and vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global duck medicine and vaccines market

Market Segmentation

By Type Insights (Revenue, USD Mn, 2020 - 2033)
- Medicine
- Vaccines
By Application Insights (Revenue, USD Mn, 2020 - 2033)
- Farm
- Government
By Region Insights (Revenue, USD Mn, 2020 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Boehringer Ingelheim International GmbH
- Ceva
- YEBIO BIOENGINEERING CO., LTD.
- NAVETCO
- Shangqiu Meilan Biological Engineering Co. Ltd.
- Merck & Co., Inc.
- EGAVET
- Bioveta, a.s.
- Jilin Zhengye Biological Products company limited
- Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.

Product Code: CMI4956

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Regulatory Scenario
Reimbursement Scenario
Technology Landscape
Product Launches
PEST Analysis

4. Global Duck Medicine and Vaccines Market, By Type, 2020 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)

5. Global Duck Medicine and Vaccines Market, By Application, 2020 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Farm
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Government
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Duck Medicine and Vaccines Market, By Region, 2020 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
YEBIO BIOENGINEERING CO., LTD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NAVETCO
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Shangqiu Meilan Biological Engineering Co.,Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EGAVET
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bioveta, a.s.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Jilin Zhengye Biological Products company limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

8. Section

Research Methodology
About Us